Canlyniadau Chwilio - G. Kriván

Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies gan Michael Borte, G. Kriván, Beáta Dérfalvi, László Maródi, Thomas Harrer, Stephen Jolles, Christelle Bourgeois, Werner Engl, Heinz Leibl, Barbara McCoy, David Gelmont, Leman Yel

Cael y testun llawn Cael y testun llawn